Controversies in thyroid pathology: The diagnosis of follicular neoplasms

Endocrine Pathology

Volumn 19, Issue 3, 2008, Pages 156-165

  Serra, Stefano ^a   Asa, Sylvia L ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CYTOKERATIN 19; FIBRONECTIN; FIBRONECTIN 1; GALECTIN 3; MOLECULAR MARKER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HBME 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; TRANSCRIPTION FACTOR PAX9; UNCLASSIFIED DRUG; TUMOR MARKER;

DIFFERENTIAL DIAGNOSIS; FOLLICLE CYST; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; ONCOGENE RAS; ONCOGENE RET; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVIEW; THYROID CARCINOMA; THYROID GLAND; THYROID TUMOR; TUMOR DIFFERENTIATION; METABOLISM; THYROID FOLLICULAR CARCINOMA;

CARCINOMA, PAPILLARY, FOLLICULAR; HUMANS; IMMUNOHISTOCHEMISTRY; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149265534     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-008-9031-5     Document Type: Review

References (60)

1. S Ezzat DA Sarti DR Cain GD Braunstein 1994 Thyroid incidentalomas. Prevalence by palpation and ultrasonography Arch Intern Med 154 16 1838 1840
2. RV Lloyd LA Erickson MB Casey KY Lam CM Lohse SL Asa 2004 Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma Am J Surg Pathol 28 10 1336 1340
3. A Jemal T Murray E Ward A Samuels RC Tiwari A Ghafoor 2005 Cancer statistics, 2005 CA Cancer J Clin 55 1 10 30
4. DeLellis RALR, Heitz PU, Eng C. Pathology and genetics tumours of endocrine organs. WHO classification of tumours. Lyon, France: IARC, 2004.
5. VA LiVolsi SL Asa 1994 The demise of follicular carcinoma of the thyroid gland Thyroid 4 2 233 236
6. RL Apel S Ezzat BV Bapat N Pan VA LiVolsi SL Asa 1995 Clonality of thyroid nodules in sporadic goiter Diagn Mol Pathol 4 2 113 121
7. S Aeschimann PA Kopp ET Kimura J Zbaeren A Tobler MF Fey 1993 Morphological and functional polymorphism within clonal thyroid nodules J Clin Endocrinol Metab 77 3 846 851
8. J Van Sande J Parma M Tonacchera S Swillens J Dumont G Vassart 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases J Clin Endocrinol Metab 80 9 2577 2585
9. J Lyons CA Landis G Harsh L Vallar K Grunewald H Feichtinger 1990 Two G protein oncogenes in human endocrine tumors Science 249 4969 655 659
10. A Porcellini I Ciullo L Laviola G Amabile G Fenzi VE Avvedimento 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy J Clin Endocrinol Metab 79 2 657 661
11. J Parma L Duprez J Van Sande J Hermans P Rocmans G Van Vliet 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas J Clin Endocrinol Metab 82 8 2695 2701
12. K Krohn D Fuhrer HP Holzapfel R Paschke 1998 Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations J Clin Endocrinol Metab 83 1 130 134
13. T Kondo S Ezzat SL Asa 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia Nat Rev Cancer 6 4 292 306
14. M Yamashina 1992 Follicular neoplasms of the thyroid. Total circumferential evaluation of the fibrous capsule Am J Surg Pathol 16 4 392 400
15. JA van Heerden ID Hay JR Goellner D Salomao JR Ebersold EJ Bergstralh 1992 Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy Surgery 112 6 1130 1136 discussion 1136-8
16. JK Harness NW Thompson MK McLeod FE Eckhauser RV Lloyd 1984 Follicular carcinoma of the thyroid gland: trends and treatment Surgery 96 6 972 980
17. BH Lang CY Lo WF Chan AK Lam KY Wan 2006 Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome World J Surg 30 5 752 758
18. CC Cheung S Ezzat L Ramyar JL Freeman SL Asa 2000 Molecular basis off Hurthle cell papillary thyroid carcinoma J Clin Endocrinol Metab 85 2 878 882
19. SL Asa 2004 My approach to oncocytic tumours of the thyroid J Clin Pathol 57 3 225 232
20. ML Carcangiu RK Sibley J Rosai 1985 Clear cell change in primary thyroid tumors. A study of 38 cases Am J Surg Pathol 9 10 705 722
21. KW Schmid NR Farid 2006 How to define follicular thyroid carcinoma? Virchows Arch 448 4 385 393
22. CC Cheung S Ezzat JL Freeman IB Rosen SL Asa 2001 Immunohistochemical diagnosis of papillary thyroid carcinoma Mod Pathol 14 4 338 342
23. Y Ito H Yoshida C Tomoda A Miya K Kobayashi F Matsuzuka 2005 HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma Anticancer Res 25 1A 179 182
24. T Mase H Funahashi T Koshikawa T Imai Y Nara Y Tanaka 2003 HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm Endocr J 50 2 173 177
25. M Papotti J Rodriguez R De Pompa A Bartolazzi J Rosai 2005 Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential Mod Pathol 18 4 541 546
26. PS de Matos AP Ferreira F de Oliveira Facuri LV Assumpcao K Metze LS Ward 2005 Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy Histopathology 47 4 391 401
27. ML Prasad NS Pellegata Y Huang HN Nagaraja A de la Chapelle RT Kloos 2005 Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors Mod Pathol 18 1 48 57
28. M Volante F Bozzalla-Cassione R DePompa E Saggiorato A Bartolazzi F Orlandi 2004 Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid Virchows Arch 445 2 183 188
29. KT Mai R Bokhary HM Yazdi J Thomas AS Commons 2002 Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hurthle cell and/or apocrine-like changes Histopathology 40 2 133 142
30. A Bartolazzi G Bussolati 2006 Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms Histopathology 48 2 212 213
31. P Mehrotra A Okpokam R Bouhaidar SJ Johnson JA Wilson BR Davies 2004 Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms Histopathology 45 5 493 500
32. LJ Mills DN Poller C Yiangou 2005 Galectin-3 is not useful in thyroid FNA Cytopathology 16 3 132 138
33. D Cvejic S Savin I Petrovic I Paunovic S Tatic K Krgovic 2005 Galectin-3 expression in papillary microcarcinoma of the thyroid Histopathology 47 2 209 214
34. KB Weber KR Shroyer DE Heinz S Nawaz MS Said BR Haugen 2004 The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer Am J Clin Pathol 122 4 524 531
35. DS Cvejic SB Savin IM Petrovic IR Paunovic SB Tatic MJ Havelka 2005 Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size Head Neck 27 12 1049 1055
36. Y Oestreicher-Kedem M Halpern P Roizman B Hardy J Sulkes R Feinmesser 2004 Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions Head Neck 26 11 960 966
37. A Gasbarri S Sciacchitano A Marasco M Papotti A Di Napoli A Marzullo 2004 Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis Br J Cancer 91 6 1096 1104
38. S Sahoo SA Hoda J Rosai RA DeLellis 2001 Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution Am J Clin Pathol 116 5 696 702
39. A Fusco G Chiappetta P Hui G Garcia-Rostan L Golden BK Kinder 2002 Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer Am J Pathol 160 6 2157 2167
40. AJ Adeniran Z Zhu M Gandhi DL Steward JP Fidler TJ Giordano 2006 Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas Am J Surg Pathol 30 2 216 222
41. W Liu SL Asa S Ezzat 2005 1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness Mol Endocrinol 19 9 2349 2357
42. W Liu W Wei D Winer AM Bamberger C Bamberger C Wagener 2007 CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases Oncogene 26 19 2747 2758
43. ED Rossi M Raffaelli A Mule A Miraglia CP Lombardi FM Vecchio 2006 Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid Histopathology 48 7 795 800
44. S Savin D Cvejic T Isic I Petrovic I Paunovic S Tatic 2006 Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors Endocr Pathol 17 1 53 60
45. DJ Finley N Arora B Zhu L Gallagher TJ Fahey 3rd 2004 Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules J Clin Endocrinol Metab 89 7 3214 3223
46. S Rebelo R Domingues AL Catarino E Mendonca JR Santos L Sobrinho 2003 Immunostaining and RT-PCR: different approaches to search for RET rearrangements in patients with papillary thyroid carcinoma Int J Oncol 23 4 1025 1032
47. KJ Rhoden K Unger G Salvatore Y Yilmaz V Vovk G Chiappetta 2006 RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma J Clin Endocrinol Metab 91 6 2414 2423
48. YE Nikiforov JM Rowland KE Bove H Monforte-Munoz JA Fagin 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children Cancer Res 57 9 1690 1694
49. G Chiappetta P Toti F Cetta A Giuliano F Pentimalli I Amendola 2002 The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions J Clin Endocrinol Metab 87 1 364 369
50. EL Maxwell CE Palme J Freeman 2006 Hurthle cell tumors: applying molecular markers to define a new management algorithm Arch Otolaryngol Head Neck Surg 132 1 54 58
51. ME Dailey S Lindsay R Skahen 1955 Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland AMA Arch Surg 70 2 291 297
52. SD Larson LN Jackson TS Riall T Uchida RP Thomas S Qiu 2007 Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway J Am Coll Surg 204 5 764 773 discussion 773-5
53. M Xing 2005 BRAF mutation in thyroid cancer Endocr Relat Cancer 12 2 245 262
54. C Ugolini R Giannini C Lupi G Salvatore P Miccoli A Proietti 2007 Presence of BRAF V600E in very early stages of papillary thyroid carcinoma Thyroid 17 5 381 388
55. AM Costa A Herrero MF Fresno J Heymann JA Alvarez J Cameselle-Teijeiro 2008 BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma Clin Endocrinol (Oxf) 68 4 618 634
56. Z Zhu M Gandhi MN Nikiforova AH Fischer YE Nikiforov 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations Am J Clin Pathol 120 1 71 77
57. TG Kroll P Sarraf L Pecciarini CJ Chen E Mueller BM Spiegelman 2000 PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected] Science 289 5483 1357 1360
58. P Castro AP Rebocho RJ Soares J Magalhaes L Roque V Trovisco 2006 PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma J Clin Endocrinol Metab 91 1 213 220
59. T Nakamura I Yana T Kobayashi E Shin K Karakawa S Fujita 1992 p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas Jpn J Cancer Res 83 12 1293 1298
60. JL Hunt M Tometsko VA LiVolsi P Swalsky SD Finkelstein EL Barnes 2003 Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid Am J Surg Pathol 27 12 1559 1564